Delivery Order SPE2DB20D9331-SPE2DB23FL0S3

Award Date 2/17/23
Potential Completion Date 3/13/23
Potential Value $96K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,535.28 contract is for the delivery of 4557853423 - Rituxan 500 mg/50 ml vial, 50 ml. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to procure a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,276.68, is for the delivery of RITUXAN 500 MG/50 ML VIAL 50ML, a specialized biologic medication. The contract is a firm fixed-price delivery order with no set-aside designation, awarded under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,415.02 contract is for the delivery of Rituxan 500 mg/50 ml vials. The delivery order is placed against DMS Pharmaceutical Group's existing $4,999,999 indefinite delivery contract with DLA, contract 4600082013 under the SPE2DB program, which allows DLA to order a broad range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $5,965.88 contract is for the supply of 4567630692 - RITUXAN 500 MG/50 ML VIAL 50ML, a specialized pharmaceutical product. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, which enables the DLA to issue delivery orders for a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $38,247.48 contract is for the delivery of RITUXAN 500 MG/50 ML VIAL 50ML to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows...
This is a delivery order award to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency Troop Support Medical. The contract is for the delivery of the pharmaceutical product Rituxan (rituximab) 500 mg/50 ml vial. The award has a firm fixed price of $3,069.17 and a completion date of March 12, 2024. The contract is not set aside and is issued under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the Defense Logistics...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $9,207.51 firm fixed-price contract is for the delivery of 4564558204 RITUXAN 500 MG/50 ML VIAL 50ML, with a performance period through May 29, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,069.17, is for the delivery of 4566748900 - Rituxan 500 MG/50 ML Vial 50ML. It is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Rituxan 500 mg/50 ml vials. The award value is $6,138.34 and the ultimate completion date is June 14, 2024. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC vehicle under the...
The U.S. government agency, the Defense Logistics Agency (DLA), awarded a delivery order contract to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, for the supply of Rituxan 500 mg/50 ml vials. The contract has a firm fixed-price of $6,138.34 and an ultimate completion date of May 3, 2024. This delivery order is part of a larger indefinite delivery contract, SPE2DB, valued at up to $4,999,999 through 2025, which allows the DLA to issue firm fixed-price orders for a...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB23FL0S3
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Rituxan 500 mg/50 ml vials, with a ceiling value of $95,618.70 and a period of performance through March 13, 2023.

The contract is a firm fixed-price delivery order and is not set aside for any specific small business category. It is issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with DLA valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide.

Generated 1/9/25, 9:11 AM